Literature DB >> 2839737

Establishment and characterization of a malignant glioma cell line, GBM8401/TSGH,NDMC.

W H Lee1, M Y Yeh, Y C Tu, S H Han, Y C Wang.   

Abstract

A permanent human brain malignant glioma cell line, GBM8401/TSGH,NDMC, has been successfully established from a 31-year-old Chinese female with brain glioblastoma multiforme (GBM) in monolayer culture and has been subcultured for more than 100 passages during 24 months in vitro. The tumor cell doubling time in vitro was approximately 38 hr. The tumorigenicity in athymic nude mice was observed; the tumor volume doubling time was approximately 4 days. Glial fibrillary acidic protein (GFAP) and 10-nm-diameter intermediate filaments were identified by immunohistochemical peroxidase-antiperoxidase (PAP), immunofluorescence assay, and transmission electron microscopic methods. The scanning electron microscope revealed numerous surface microvilli and various-sized blebs. Karyotypic analysis showed this malignant glioma cell line to be of human origin, near-diploid with a modal chromosome number of 48,XX.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2839737     DOI: 10.1002/jso.2930380309

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  7 in total

1.  Differential expression of centrosomal proteins at different stages of human glioma.

Authors:  Joon-Khim Loh; Ann-Shung Lieu; Chia-Hua Chou; Fang-Yi Lin; Chia-Hung Wu; Sheng-Long Howng; Chung-Ching Chio; Yi-Ren Hong
Journal:  BMC Cancer       Date:  2010-06-09       Impact factor: 4.430

2.  ARID4B Knockdown Suppresses PI3K/AKT Signaling and Induces Apoptosis in Human Glioma Cells.

Authors:  Siou-Min Luo; Wen-Chiuan Tsai; Chia-Kuang Tsai; Ying Chen; Dueng-Yuan Hueng
Journal:  Onco Targets Ther       Date:  2021-03-10       Impact factor: 4.147

3.  Pharmacokinetic analysis of 111 in-labeled liposomal Doxorubicin in murine glioblastoma after blood-brain barrier disruption by focused ultrasound.

Authors:  Feng-Yi Yang; Hsin-Ell Wang; Ren-Shyan Liu; Ming-Che Teng; Jia-Je Li; Maggie Lu; Ming-Cheng Wei; Tai-Tong Wong
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

4.  Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.

Authors:  Dawn Q Chong; Xin Y Toh; Ivy A W Ho; Kian C Sia; Jennifer P Newman; Yulyana Yulyana; Wai-Hoe Ng; Siang H Lai; Mac M F Ho; Nivedh Dinesh; Chee K Tham; Paula Y P Lam
Journal:  BMC Cancer       Date:  2015-04-11       Impact factor: 4.430

5.  Contribution of the Testosterone Androgen Receptor-PARD3B Signaling Axis to Tumorigenesis and Malignance of Glioblastoma Multiforme through Stimulating Cell Proliferation and Colony Formation.

Authors:  Jr-Di Yang; Jui-Tai Chen; Shing-Hwa Liu; Ruei-Ming Chen
Journal:  J Clin Med       Date:  2022-08-17       Impact factor: 4.964

6.  Demethoxycurcumin Suppresses Human Brain Glioblastoma Multiforme GBM 8401 Cell Xenograft Tumor in Nude Mice In Vivo.

Authors:  Yi-Ping Huang; Yi-Shih Ma; Chao-Lin Kuo; Ching-Lung Liao; Po-Yuan Chen; Shu-Fen Peng; Fei-Ting Hsu; Kuang-Chi Lai
Journal:  Int J Mol Sci       Date:  2021-05-23       Impact factor: 5.923

7.  Inducement of mitosis delay by cucurbitacin E, a novel tetracyclic triterpene from climbing stem of Cucumis melo L., through GADD45γ in human brain malignant glioma (GBM) 8401 cells.

Authors:  Y-C Hsu; M-J Chen; T-Y Huang
Journal:  Cell Death Dis       Date:  2014-02-27       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.